SCHEMBL4188710

SCHEMBL4188710

COc1ccc2oc(CC(C)(C)CO)c(CC(=O)C(C)(C)C)c2c1

nearest known ligand 0.46

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
MTNR1A P48039 14/20 0.46
MTNR1B P49286 13/20 0.46
SLC22A12 Q96S37 1/20 0.42
NQO1 P15559 1/20 0.42
KDM4E B2RXH2 2/20 0.41
NPC1 O15118 2/20 0.41
ALDH1A1 P00352 2/20 0.41
RAB9A P51151 2/20 0.41
SMN1; SMN2 Q16637 2/20 0.41
CYP2C9 P11712 1/20 0.41
MAPT P10636 1/20 0.41
HPGD P15428 1/20 0.41
CASP3 P42574 1/20 0.41
SENP8 Q96LD8 1/20 0.41
SENP7 Q9BQF6 1/20 0.41
SENP6 Q9GZR1 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4193929 0.82 MTNR1A (0.49) MTNR1AMTNR1B
SCHEMBL4181685 0.79 KDM4E (0.50) MTNR1AMTNR1BNQO1KDM4ENPC1
SCHEMBL4188707 0.76 NQO1 (0.43) MTNR1AMTNR1BSLC22A12NQO1KDM4E
SCHEMBL4187070 0.71 KDM4E (0.52) MTNR1AMTNR1BNQO1KDM4ENPC1
SCHEMBL4193680 0.70 KDM4E (0.46) MTNR1AMTNR1BSLC22A12NQO1KDM4E
SCHEMBL4181687 0.70 KDM4E (0.48) MTNR1AMTNR1BNQO1KDM4ENPC1
SCHEMBL4193928 0.67 SLC22A12 (0.41) MTNR1AMTNR1BSLC22A12NQO1KDM4E
SCHEMBL4187155 0.67 NQO1 (0.40) MTNR1AMTNR1BSLC22A12NQO1KDM4E
SCHEMBL11544887 0.66 KDM4E (0.52) SLC22A12KDM4ENPC1ALDH1A1RAB9A
SCHEMBL4193683 0.66 KDM4E (0.46) MTNR1AMTNR1BNQO1KDM4ENPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1664011-A4 OPHTHALMIC COMPOSITIONS FOR TREATING OCULAR HYPERTENSION MERCK & CO INC (US) 2009-02-25 EP disclosed
EP-1664011-A2 OPHTHALMIC COMPOSITIONS FOR TREATING OCULAR HYPERTENSION Merck & Co., Inc. (US) 2006-06-07 EP disclosed
WO-2005020917-A2 OPHTHALMIC COMPOSITIONS FOR TREATING OCULAR HYPERTENSION MERCK & CO., INC. (US) 2005-03-10 WO disclosed